Ambrilia Biopharma Inc.

Details Ambrilia Biopharma Inc. Ambrilia Biopharma Inc.

www.ambrilia.com

Quebec

Montreal

Downtown Montreal

Corporation

active

Biopharmaceutical company developing early to mid-stage therapeutics in the fields of oncology and infectious diseases. Product portfolio includes an anti-cancer therapeutic peptide (PCK3145), a Tumor Vasculature Targeting (TVT) technology platform, an improved, prolonged release formulation of Octreotide, a new formulation of Goserelin and promising anti-HIV treatments (PPL-100, Integrase Inhibitor Program).
Country of Ownership: Canada
Exporting: Yes
Primary Industry (NAICS): 325410 - Pharmaceutical and Medicine Manufacturing
Alternate Industries (NAICS): 541710 - Research and Development in the Physical, Engineering and Life Sciences
Primary Business Activity: Manufacturer / Processor / Producer

Products:
Mid-stage therapeutics in the fields of oncology and infectious diseases

Affiliated with

Also associated with

No associations

Rating

Ambrilia Biopharma Inc. does not yet have a rating. At this time, there are no reviews or comments for this company.

If you have personal experience with Ambrilia Biopharma Inc., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ambrilia Biopharma Inc. will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-COD-O-27520